Biohaven has a one year low of $26.80 and a one year high of $62.21. In related news, Director John W. Childs bought 29,000 shares of the company’s stock in a transaction on Monday, December 30th.

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a phase 2/3 trial. The registrational study assessed BHV-7000, a drug designed to selectively activate Kv7.2/Kv7.3 ...

John Oliver, host of "Last Week Tonight" on HBO, is a 21-time Emmy winner. But he still remembers how frequently he bombed as a young comedian in the U.K. When he was starting out, Oliver used to ...

As a group, sell-side analysts expect that Biohaven will post -8.9 earnings per share for the current fiscal year. In other news, Director John W. Childs acquired 32,700 shares of the business’s ...

Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report ... in 2023 7 Stocks to Buy and Hold Forever In other news, Director John W. Childs acquired 32,700 shares of the company’s stock in ...

In this article, we are going to take a look at where Biohaven Ltd. (NYSE:BHVN) stands against other stocks with heavy insider buying in 2025. Insider trading is often seen as an important ...

Robert John, an itinerant singer-songwriter who was working in construction before scoring a Number One hit with 1979’s “Sad Eyes,” died Monday. He was 79. Michael Pedrick, John’s son ...

Morgan Stanley lowered the firm’s price target on Biohaven (BHVN) to $63 from $69 and keeps an Overweight rating on the shares. Biohaven reported Q4 earnings on March 3 and provided “mixed ...

In other Biohaven news, Director John W. Childs acquired 29,000 shares of the company’s stock in a transaction dated Monday, December 30th. The shares were purchased at an average cost of $35.94 ...

In other Biohaven news, Director John W. Childs purchased 32,700 shares of the stock in a transaction on Tuesday, March 4th. The shares were purchased at an average price of $30.47 per share ...

On average, equities analysts expect that Biohaven will post -8.9 EPS for the current year. In related news, Director John W. Childs purchased 32,700 shares of Biohaven stock in a transaction ...

John earned a Grammy nomination for "Sad Eyes" Michael Ochs Archives/Getty Robert John, the singer-songwriter behind the chart-topping hit "Sad Eyes," has died. He was 79. John's son Michael ...